Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex

Psychopharmacology

Volumn 127, Issue 1, 1996, Pages 83-87

  Tanda, Gianluigi ^a   Frau, Roberto ^a   Di Chiara, Gaetano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antidepressants; Desipramine; Dopamine; Fluoxetine; Microdialysis; Noradrenaline; Prefrontal cortex; Rat; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; DOPAMINE; FLUOXETINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE TIME EFFECT RELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PREFRONTAL CORTEX; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROVOCATION TEST; RAT;

EID: 0029795359     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02805978     Document Type: Article

References (25)

1. 1A receptor selective ligands. (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg's Arch Pharmacol 347:353-362
2. Baldessarini RJ (1980) Drugs and the treatment of psychiatric disorders. In: Gilman AG et al. (eds) The pharmacological basis of therapeutics. MacMillan, New York, pp 391-447
3. Baxter LR, Schwartz JM, Phelps ME, Mazziota JC, Guze BH, Selin CE, Gerner RH, Sumida RM (1989) Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243-254
4. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not raphe nuclei. Synapse 15:243
5. 18F]2-deoxyglucose in affective illness. J Affect Disord 10:137-145
6. Caccia S, Cappi M, Fracasso C, Garattini S (1990) influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology 100:509-514
7. Carboni E, Di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 32: 637-645
8. Carboni E, Tanda G, Frau R, Di Chiara G (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55: 1067-1070
9. 1A receptors in depression and anxiety. Raven, New York, pp 55-81
10. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME (1992) A functional anatomical study of unipolar depression. J Neurosci 12:3628-3641
11. Fuller RW, Wong DT, Robertson DW (1991) Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev 11:17-34
12. Hollister LE (1978) Tricyclic antidepressants. N End J Med 299: 1168-1172
13. Imperato A, Di Chiara G (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: A new method for the study of the in vivo release of endogenous dopamine and metabolites. J Nerosci 4:966-977
14. Imperato A, Di Chiara G (1985) Dopamine release and metabolism in awake after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci 5:297-306
15. Jimerson DC (1987) Role of dopamine mechanisms in the affective disorders. In: Melzer HY (ed) Pscychopharmacology: the third generation of progress. Raven, New York, pp 505-511
16. Lemberger L, Fuller RW, Zerbe RL (1985) Use of specific serotonin uptake inhibitors as antidepressants. Clin Neuropharmacol 8:299-317
17. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979) Stereotaxic atlas of the rat brain. Plenum Press, New York
18. Pinder RM, Fink M (1982) Pharmacological aspects of mianserin. Acta Psychiatr Scand Suppl 302:59-71
19. Potts BD, Parli CJ (1992) Analysis of the enantiomers of fluoxetine and norfluoxetine in plasma and tissue using chiral derivatization and normal-phase liquid chromatography. J Liq Chromatogr 15:665-681
20. Tanda G, Carboni E, Frau R, Di Chiara G (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115:285-288
21. 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology 119:15-19
22. Tanda G, Bassareo V, Di Chiara G (1996) Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology 123:127-130
23. 3 antagonists and benzodiazepines. Their comparative pharmacology. Wiley, New York, pp 159-195
24. Willner P (1983a) Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res Rev 6:211-224
25. Willner P (1983b) Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments. Brain Res Rev 6:237-246